Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multicenter analytical evaluation of a high-sensitivity troponin T assay.

Clinica chimica acta; international journal of clinical chemistry·2011
Same author

How does Trichinella spiralis make itself at home?

Parasitology today (Personal ed.)·2006
Same author

Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease.

Neuropathology and applied neurobiology·2006
Same author

Language barriers and paediatric burns: does education make a difference?

Burns : journal of the International Society for Burn Injuries·2006
Same author

Anatomical localization of leucine-rich repeat kinase 2 in mouse brain.

Neuroscience·2006
Same author

Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.

Journal of medical genetics·2005

Related Experiment Video

Updated: Jul 14, 2026

Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI
07:31

Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI

Published on: November 1, 2014

Cyclic eosinophilic myositis and hyperimmunoglobulin-E.

W A Symmans, C H Beresford, D Bruton

    Annals of Internal Medicine
    |January 1, 1986
    PubMed
    Summary

    This study details a unique cyclic syndrome in a 40-year-old man characterized by weight gain, eosinophilic myositis, high immunoglobulin E (IgE), and hypereosinophilia. Prednisone therapy effectively managed these recurrent episodes, suggesting a potential treatment for this rare condition.

    More Related Videos

    Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
    03:23

    Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis

    Published on: May 10, 2024

    Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
    10:55

    Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

    Published on: October 31, 2025

    Related Experiment Videos

    Last Updated: Jul 14, 2026

    Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI
    07:31

    Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI

    Published on: November 1, 2014

    Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
    03:23

    Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis

    Published on: May 10, 2024

    Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
    10:55

    Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

    Published on: October 31, 2025

    Area of Science:

    • Internal Medicine
    • Immunology
    • Neurology

    Background:

    • A 40-year-old male presented with a 9-year history of recurrent episodes involving weight gain and eosinophilic myositis.
    • These episodes were consistently associated with elevated immunoglobulin E (IgE) levels and marked hypereosinophilia.

    Observation:

    • During episodes, body weight increased by up to 10.8%, eosinophil counts reached 41.3 x 10^9 cells/L, and IgE levels peaked at 18,000 IU/mL.
    • The clinical and laboratory parameters followed a distinct sequential pattern.
    • Parasitic causes were ruled out, and anthelmintic treatments proved ineffective.

    Findings:

    • Low-dose daily prednisone (10 mg/d) initiated in July 1982 led to an immediate reduction in episode severity.
    • Prednisone therapy also progressively lengthened the cycle duration from 35 to 170 days.
    • No further episodes occurred after March 1984, with the patient maintained on alternate-day prednisone (12.5 mg).

    Implications:

    • This case highlights a unique, cyclic syndrome with skeletal muscle as the primary target organ.
    • The findings suggest that corticosteroid therapy can effectively manage this apparently benign, self-limiting condition.
    • This case contributes to the understanding of rare eosinophilic disorders and their management.